Skip to content
★ Sign in to follow
Livsmed Inc logo

Livsmed Inc Stock: price and insider trades · South Korea

리브스메드

KR·Mcap ₩1THealth Care

No insider purchase over the last 90 days. The latest, by 김욱은, was filed 10 Jul 2026.

Insider Decl.
26
Thresholds
n/a
Buy Volume
€233M
19 ops. · all time
Sell Volume
€73M
6 ops. · all time

Who traded when

BuySale
스톤브릿지벤처스1 buy5 sales
이정주3 buys1 sale
장동규3 buys
김욱은2 buys
오세윤2 buys
이동욱2 buys

+5 other insiders

Since the insiders bought

  • Filed 22 Apr 2026 · 201 days ago · €71k
    -33.9%
    Entry ₩59,600 · Close 30 Oct 2026 ₩39,400
  • Filed 07 Apr 2026 · 216 days ago · €53.1M
    -40.8%
    Entry ₩66,600 · Close 30 Oct 2026 ₩39,400
  • Filed 02 Jan 2026 · 311 days ago · €72.3M
    -30.1%
    Entry ₩56,400 · Close 30 Oct 2026 ₩39,400

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Fundamental score
Ranked 22,266 of 26,913 companies
28.4
score / 100
Value
26
Quality
31
FCF yld-4.0%
Earn yld-2.2%
EV/EBITDA·
ROE-24%
Gross mgn58%
Net mgn-45%
Debt/EBITDA·
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

₩40,400
Analyst consensus
1 analysts
1.00/5
₩90,000Target ₩90,000(+123%)₩90,000
Income statement
Revenue₩51.2B
Gross profit₩29.5B58% margin
EBITDA-₩19.3B-38% margin
Net income-₩22.9B-50.2% margin
Balance sheet & cash
Market cap₩1T
Total debt₩11.6B
Free Cash Flow-₩42.5B
Debt / Equity8%
Profitability & ownership
ROE-24.0%
ROA-14.8%
% insiders44.3%
% institutions19.0%
Last declaration on 10 July 2026
Declarations26 total
  • ▲
    대량보유자Executives(filed)
    €7,376est.0DART
    300 sharesKRXDART:20260710000580
    Canonical exit: 8 Oct 2026 (T+90)
  • ▲
    부사장Executives(filed)
    €261kest.0DART
    10,600 sharesShareKRXDART:20260710000639
    Canonical exit: 8 Oct 2026 (T+90)
  • ▲
    상무Executives(filed)
    €1.3Mest.0DART
    51,000 sharesShareKRXDART:20260710000651
    Canonical exit: 8 Oct 2026 (T+90)
  • ▲
    전무Executives(filed)
    €1.3Mest.0DART
    51,000 sharesShareKRXDART:20260710000603
    Canonical exit: 8 Oct 2026 (T+90)
  • ▲
    상무Executives(filed)
    €1.6Mest.0DART
    65,000 sharesShareKRXDART:20260710000592
    Canonical exit: 8 Oct 2026 (T+90)
  • ▲
    이사Executives
    €71kest.0DART
    2,000 sharesShareKRXDART:20260422000395
    Canonical exit: 14 Jul 2026 (T+90)
  • ▲
    Executives
    €53.1Mest.0DART
    1,465,662 sharesKRXDART:20260407003261
    Canonical exit: 24 Mar 2026 (T+90)
  • ●
    Executives
    Executives(filed)
    0DART
  • ▼
    Executives
    €11.9Mest.0DART
    241,358 sharesKRXDART:20260310003065
  • ▼
    Executives
    €17.1Mest.0DART
    385,390 sharesKRXDART:20260210000663
  • ▼
    Executives
    €12kest.0DART
    250 sharesKRXDART:20260128000456
  • ▲
    부사장Executives(filed)
    €140kest.0DART
    3,000 sharesShareKRXDART:20260128000483
    Canonical exit: 28 Apr 2026 (T+90)
  • ▲
    이사Executives(filed)
    €140kest.0DART
    3,000 sharesShareKRXDART:20260128000461
    Canonical exit: 28 Apr 2026 (T+90)
  • ▲
    전무Executives(filed)
    €140kest.0DART
    3,000 sharesShareKRXDART:20260128000479
    Canonical exit: 28 Apr 2026 (T+90)
  • ▲
    상무Executives(filed)
    €6.3Mest.0DART
    135,000 sharesShareKRXDART:20260128000490
    Canonical exit: 28 Apr 2026 (T+90)
  • ▲
    상무Executives(filed)
    €140kest.0DART
    3,000 sharesShareKRXDART:20260128000496
    Canonical exit: 28 Apr 2026 (T+90)
  • ▲
    상무Executives(filed)
    €140kest.0DART
    3,000 sharesShareKRXDART:20260128000465
    Canonical exit: 28 Apr 2026 (T+90)
  • ▼
    Executives
    €15.0Mest.0DART
    414,690 sharesKRXDART:20260123000035
  • ▼
    Executives
    €16.8Mest.0DART
    507,595 sharesKRXDART:20260116000401
  • ▼
    Executives
    €12.2Mest.0DART
    382,715 sharesKRXDART:20260109000485
  • ▲
    이사Executives(filed)
    €164est.0DART
    5 sharesShareKRXDART:20260106000559
    Canonical exit: 6 Apr 2026 (T+90)
  • ▲
    Related company / holdingExecutives
    €72.3Mest.0DART
    2,290,752 sharesKRXDART:20260102000431
    Canonical exit: 24 Mar 2026 (T+90)
  • ▲
    상무Executives(filed)
    €481kest.0DART
    15,226 sharesShareKRXDART:20260102000438
    Canonical exit: 2 Apr 2026 (T+90)
  • ▲
    Executives
    0DART
    9,781,726 sharesKRXDART:20260102000434
    Canonical exit: 24 Mar 2026 (T+90)
  • ▲
    대표이사Executives(filed)
    0DART
    9,708,000 sharesShareKRXDART:20260102000448
    Canonical exit: 2 Apr 2026 (T+90)

25 of 26 declarations

About Livsmed Inc

The record of 리브스메드 (Livsmed Inc) is new: its first filing was published on December 30, 2025, and 25 of its 26 filings date from 2026. From January 2 to 28, 2026, seven distinct filers bought shares, with no amount published. The register holds 19 purchases and 6 sales, or 76% purchases on the market side.

The South Korean business, in health care and pharma, is valued at KRW 1,045.2 billion, and 44.3% of the capital is held by filers. Twelve filers appear, among them 스톤브릿지벤처스, with 6 filings (one purchase and 5 sales), and 이정주 (대량보유자), with 4 filings (3 purchases and one sale). Three executives show up with purchases only: 장동규 (상무), 3; 오세윤 (부사장), 2; 김욱은 (상무), 2.

Read moreShow less

The latest filing published is from July 10, 2026. Over the last twelve months, which cover the whole history of the record, 26 filings of which 19 purchases and 6 sales. A trade is published 7 days after its date, as a median, measured on 10 filings.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations